olanzapine (Zyprexa)

DRUG3 trials

Sponsors

FDA Office of Orphan Products Development, Massachusetts General Hospital, VA Connecticut Healthcare System

Conditions

Autistic DisorderBipolar DisorderManiaSchizoaffective DisorderSchizophrenia

Phase 2

A Controlled Study of Olanzapine in Children With Autism

CompletedNCT00057408

FDA Office of Orphan Products DevelopmentAutistic Disorder

Start: 2003-05-31End: 2005-09-30Target: 78Updated: 2015-03-25

Phase 3

Zyprexa and Task Engagement in Schizophrenia

WithdrawnNCT00440843

VA Connecticut Healthcare SystemSchizoaffective Disorder, Schizophrenia

Start: 2007-02-28End: 2012-06-30Updated: 2013-12-23

Phase 4

Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder

CompletedNCT00181935

Massachusetts General HospitalBipolar Disorder, Mania

Start: 2001-03-31End: 2004-07-31Target: 40Updated: 2013-05-06